Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-21 4:43 pm Sale | 13D | Harpoon Therapeutics Inc. HARP | Arix Bioscience plc | 323,893 1.500% | -2,915,036 (-90.00%) | View |
| 2023-03-29 4:27 pm Purchase | 13D | Harpoon Therapeutics Inc. HARP | Arix Bioscience plc | 3,238,929 8.400% | 1,048,007 (+47.83%) | View |
| 2023-02-10 4:40 pm Sale | 13D | CONTEXTLOGIC INC LOGC | Arix Bioscience plc | 0 0.000% | -1,834,531 (Position Closed) | View |
| 2023-02-10 4:37 pm Sale | 13G | Aura Biosciences Inc. AURA | Arix Bioscience plc | 1,508,483 4.100% | -91,593 (-5.72%) | View |
| 2022-05-04 4:36 pm Sale | 13D | CONTEXTLOGIC INC LOGC | Arix Bioscience plc | 1,834,531 5.570% | -348,680 (-15.97%) | View |
| 2022-02-15 3:15 pm Sale | 13D | CONTEXTLOGIC INC LOGC | Arix Bioscience plc | 2,183,211 6.620% | -800,318 (-26.82%) | View |
| 2022-02-10 4:35 pm Purchase | 13G | Aura Biosciences Inc. AURA | Arix Bioscience plc | 1,600,076 29.210% | 91,593 (+6.07%) | View |
| 2021-11-10 2:33 pm Purchase | 13G | Aura Biosciences Inc. AURA | Arix Bioscience plc | 1,508,483 5.310% | 1,508,483 (New Position) | View |
| 2021-10-26 3:42 pm Purchase | 13D | CONTEXTLOGIC INC LOGC | Arix Bioscience plc | 2,983,529 9.250% | 602,093 (+25.28%) | View |
| 2021-07-20 4:21 pm Purchase | 13D | Enliven Therapeutics Inc. ELVN | Arix Bioscience plc | 2,344,072 9.000% | 1,275,817 (+119.43%) | View |
| 2021-07-15 5:41 pm Sale | 13D | Harpoon Therapeutics Inc. HARP | Arix Bioscience plc | 2,190,922 6.700% | -17,745 (-0.80%) | View |
| 2021-02-17 5:01 pm Sale | 13D | Autolus Therapeutics plc AUTL | Arix Bioscience plc | 3,319,866 4.800% | -50,000 (-1.48%) | View |
| 2021-01-12 4:15 pm Purchase | 13D | Harpoon Therapeutics Inc. HARP | Arix Bioscience plc | 2,208,667 6.900% | 14,963 (+0.68%) | View |
| 2021-01-08 4:16 pm Sale | 13D | Enliven Therapeutics Inc. ELVN | Arix Bioscience plc | 1,068,255 6.100% | -393,751 (-26.93%) | View |
| 2021-01-08 4:15 pm Purchase | 13D | Autolus Therapeutics plc AUTL | Arix Bioscience plc | 3,369,866 6.400% | 208,333 (+6.59%) | View |
| 2020-12-04 5:28 pm Sale | 13D | Enliven Therapeutics Inc. ELVN | Arix Bioscience plc | 1,462,006 8.400% | -92,552 (-5.95%) | View |
| 2020-09-29 4:00 pm Sale | 13D | CONTEXTLOGIC INC LOGC | Arix Bioscience plc | 2,381,436 10.100% | -597,587 (-20.06%) | View |
| 2020-06-05 4:31 pm Sale | 13D | ITERUM THERAPEUTICS PLC SHS NE ITRM | Arix Bioscience plc | 329,193 2.200% | -766,864 (-69.97%) | View |
| 2020-06-01 5:00 pm Sale | 13D | Harpoon Therapeutics Inc. HARP | Arix Bioscience plc | 2,193,704 8.800% | -415,213 (-15.92%) | View |
| 2020-03-24 4:15 pm Purchase | 13D | Enliven Therapeutics Inc. ELVN | Arix Bioscience plc | 1,554,558 9.400% | 1,554,558 (New Position) | View |